Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-01

Clinical Trial Update: Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a non-surgical treatment for muscle-invasive bladder cancer using anti-PD-1 therapy in combination with chemoradiation; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PD-1 inhibitor (anti-PD-1 therapy)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor | Phase 2 | Status: ACTIVE_NOT_RECRUITING